Table 3.
Duration (months) of antithrombotic treatment for the index VTE event
| n (%) | Overall (N = 600) |
|---|---|
| Scheduled (intended) duration | |
| 3 months | 122 (20.3) |
| 6 months | 267 (44.5) |
| 9 months | 2 (0.3) |
| 12 months | 4 (0.7) |
| No scheduled stop date | 205 (34.2) |
| Actual duration | |
| < 3 months | 52 (8.7) |
| 3–6 months | 285 (47.5) |
| > 6 months | 237 (39.5) |
| Unknown (loss of follow-up) | 26 (4.3) |
Abbreviations n number of patients with variable ,VTE Venous Thromboembolism